Matches in Wikidata for { <http://www.wikidata.org/entity/Q91619225> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q91619225 description "article scientifique publié en 2019" @default.
- Q91619225 description "artículu científicu espublizáu en mayu de 2019" @default.
- Q91619225 description "scientific article published on 31 May 2019" @default.
- Q91619225 description "wetenschappelijk artikel" @default.
- Q91619225 description "наукова стаття, опублікована 31 травня 2019" @default.
- Q91619225 name "A Quality-adjusted Time Without Symptoms or Toxicity (Q-TWiST) Analysis of Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma (aRCC)" @default.
- Q91619225 name "A Quality-adjusted Time Without Symptoms or Toxicity (Q-TWiST) Analysis of Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma (aRCC)" @default.
- Q91619225 type Item @default.
- Q91619225 label "A Quality-adjusted Time Without Symptoms or Toxicity (Q-TWiST) Analysis of Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma (aRCC)" @default.
- Q91619225 label "A Quality-adjusted Time Without Symptoms or Toxicity (Q-TWiST) Analysis of Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma (aRCC)" @default.
- Q91619225 prefLabel "A Quality-adjusted Time Without Symptoms or Toxicity (Q-TWiST) Analysis of Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma (aRCC)" @default.
- Q91619225 prefLabel "A Quality-adjusted Time Without Symptoms or Toxicity (Q-TWiST) Analysis of Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma (aRCC)" @default.
- Q91619225 P1433 Q91619225-E01149FD-BDEE-467B-BCB4-E2BC93FD2DFF @default.
- Q91619225 P1476 Q91619225-21AC1030-F066-4110-9013-7F9619610599 @default.
- Q91619225 P2093 Q91619225-1D7BB39C-EA56-4D1E-BA29-04F1CE848D3B @default.
- Q91619225 P2093 Q91619225-2E514BED-B792-436B-ADCC-9E6F7E5BB92E @default.
- Q91619225 P2093 Q91619225-7259AB24-1DFD-4E39-BF39-A07A1FE5FD40 @default.
- Q91619225 P2093 Q91619225-7A58171B-55F8-4AC3-BB17-1F73FC868E4F @default.
- Q91619225 P2093 Q91619225-A88229DC-3176-4DA3-81C8-E825E1F9E543 @default.
- Q91619225 P2093 Q91619225-AB4120DC-35FE-4564-8C90-ABE02252C219 @default.
- Q91619225 P2093 Q91619225-B1DDCF1C-DF60-48F5-BDDC-056C7ED2BC4E @default.
- Q91619225 P304 Q91619225-D8DB5761-4399-4764-A625-B764E907CDAE @default.
- Q91619225 P31 Q91619225-F9E3EE53-061F-465B-8783-165D9197A8D5 @default.
- Q91619225 P356 Q91619225-A895C5D3-5D03-4D5D-8872-B49ECB4EB868 @default.
- Q91619225 P433 Q91619225-33B5E076-2D89-4E8B-BC0D-93BFCD352686 @default.
- Q91619225 P478 Q91619225-991159E9-66DB-4BE8-B198-6E8C44D9F4D3 @default.
- Q91619225 P577 Q91619225-E48A7040-66C2-4C0C-B2B1-5FDDEEC49AA3 @default.
- Q91619225 P698 Q91619225-ED19E8A9-FFF5-4002-AD71-C5E4185910BD @default.
- Q91619225 P921 Q91619225-2CE60CCC-5615-4A57-9471-6AE656C4C7EF @default.
- Q91619225 P356 J.CLGC.2019.05.010 @default.
- Q91619225 P698 31272883 @default.
- Q91619225 P1433 Q332266 @default.
- Q91619225 P1476 "A Quality-adjusted Time Without Symptoms or Toxicity (Q-TWiST) Analysis of Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma (aRCC)" @default.
- Q91619225 P2093 "Caitlyn T Solem" @default.
- Q91619225 P2093 "David Cella" @default.
- Q91619225 P2093 "Justin Doan" @default.
- Q91619225 P2093 "Linlin Luo" @default.
- Q91619225 P2093 "Marc Botteman" @default.
- Q91619225 P2093 "Robert J Motzer" @default.
- Q91619225 P2093 "Ruchitbhai Shah" @default.
- Q91619225 P304 "356-365.e1" @default.
- Q91619225 P31 Q13442814 @default.
- Q91619225 P356 "10.1016/J.CLGC.2019.05.010" @default.
- Q91619225 P433 "5" @default.
- Q91619225 P478 "17" @default.
- Q91619225 P577 "2019-05-31T00:00:00Z" @default.
- Q91619225 P698 "31272883" @default.
- Q91619225 P921 Q1164529 @default.